Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 294 publications
GLP-1-targeted therapies for alcohol and other substance use disorders: a new era on the horizon?
Journal: The Journal of clinical investigation
Published: September 01, 2026
Mediators of treatment response in a clinical trial of naltrexone and bupropion for methamphetamine use disorder: A longitudinal mediation analysis.
Journal: Journal of psychopharmacology (Oxford, England)
Published: July 27, 2026
Holistic Health Approaches for People with Alcohol Use Disorder: Protocol for a Scoping Review.
Journal: JMIR research protocols
Published: June 10, 2026
Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder: A Meta-Analysis of 12 Randomized Controlled Trials.
Journal: JAMA psychiatry
Published: June 03, 2026
Letter: Pharmacotherapy for Alcohol Dependence in Cirrhosis-By Addressing One Issue Do We Create Another? Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 01, 2026
Mediators of Treatment Response in Clinical Trial of Naltrexone and Bupropion for Methamphetamine Use Disorder: A Longitudinal Mediation Analysis.
Journal: medRxiv : the preprint server for health sciences
Published: May 25, 2026
Stimulant Craving and Drug Use Dynamics: A Cross-Lagged Residual Dynamic Structural Equation Modeling Study.
Journal: medRxiv : the preprint server for health sciences
Published: May 25, 2026
Letter: Unmasking the Risks-The Need for Robust Data on Baclofen in Cirrhotic Patients. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 24, 2026
Brain penetrant calcium channel blockers do not reduce alcohol consumption: Converging results from two large independent cohort studies using electronic health records.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
A Secondary, Subgroup Analysis of Alcohol Cue-Exposure Craving in Response to Pharmacological Inhibition of the Growth Hormone Secretagogue Receptor With PF-5190457.
Journal: Alcohol, clinical & experimental research
Published: March 18, 2026
GLP-1 Receptor Agonist Prescription Patterns in the All of Us Research Program.
Journal: medRxiv : the preprint server for health sciences
Published: February 26, 2026
Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 24, 2026
Last Updated: 09/26/2026